Atridia Pty Ltd. Report issue

For profit Phase 1
Founded: Sydney Australia (2015)

Organization Overview

First Clinical Trial
2016
NCT02759666
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Atridia Pty Ltd.